Robert W. Duggan - Dec 1, 2023 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Role
Director, 10%+ Owner
Signature
/s/ Kenneth B. Stratton, as Attorney-in-Fact
Stock symbol
PLSE
Transactions as of
Dec 1, 2023
Transactions value $
$413,592
Form type
4
Date filed
12/5/2023, 08:31 PM
Previous filing
Dec 4, 2023
Next filing
Dec 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLSE Common Stock Purchase $414K +45.6K +21.41% $9.07 259K Dec 1, 2023 See footnote F1, F2
holding PLSE Common Stock 36.6M Dec 1, 2023 Direct
holding PLSE Common Stock 492K Dec 1, 2023 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Volume-weighted average price.
F2 Shares are held by Blazon Corporation, of which the Reporting Person is the majority shareholder.
F3 Shares are held by Genius Inc., of which the Reporting Person is the sole shareholder.